Sanofi (France) Pulls Filings for Anticoagulant Mulsevo

Published: Jul 10, 2012

PARIS, July 9 (Reuters) - Sanofi has withdrawn its application to sell Mulsevo, an experimental drug to prevent blood clots in chemotherapy patients, in the European Union after it failed to win the backing of the U.S. regulator last month, the European Medicines Agency said on Monday.

Sanofi said in its withdrawal letter that it decided to withdraw all applications globally following comments by regulatory agencies, according to an EMA statement.

Back to news